Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Outset Medical Inc (NASDAQ: OM) was $12.61 for the day, up 1.29% from the previous closing price of $12.45. In other words, the price has increased by $1.29 from its previous closing price. On the day, 0.54 million shares were traded. OM stock price reached its highest trading level at $13.175 during the session, while it also had its lowest trading level at $11.62.
Ratios:
Our analysis of OM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 7.47. In the meantime, Its Debt-to-Equity ratio is 0.64 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’25 when Trigg Leslie sold 904 shares for $12.88 per share. The transaction valued at 11,644 led to the insider holds 122,328 shares of the business.
Nash Marc sold 243 shares of OM for $3,130 on Aug 15 ’25. The SVP Operations and R&D now owns 42,898 shares after completing the transaction at $12.88 per share. On Aug 15 ’25, another insider, Brottem John L., who serves as the General Counsel of the company, sold 383 shares for $12.88 each. As a result, the insider received 4,933 and left with 46,883 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 224031680 and an Enterprise Value of 142212688. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.88 while its Price-to-Book (P/B) ratio in mrq is 1.48. Its current Enterprise Value per Revenue stands at 1.192 whereas that against EBITDA is -2.004.
Stock Price History:
The Beta on a monthly basis for OM is 2.15, which has changed by 0.37814212 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, OM has reached a high of $25.35, while it has fallen to a 52-week low of $5.85. The 50-Day Moving Average of the stock is -9.48%, while the 200-Day Moving Average is calculated to be -12.91%.
Shares Statistics:
OM traded an average of 244.89K shares per day over the past three months and 292450 shares per day over the past ten days. A total of 17.77M shares are outstanding, with a floating share count of 17.00M. Insiders hold about 4.30% of the company’s shares, while institutions hold 108.01% stake in the company. Shares short for OM as of 1759190400 were 1724184 with a Short Ratio of 7.04, compared to 1756425600 on 1950146. Therefore, it implies a Short% of Shares Outstanding of 1724184 and a Short% of Float of 9.810001.
Earnings Estimates
. The current market rating for Outset Medical Inc (OM) reflects the collective analysis of 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.58, with high estimates of -$0.54 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$3.9 and -$5.29 for the fiscal current year, implying an average EPS of -$4.3. EPS for the following year is -$2.61, with 4.0 analysts recommending between -$2.15 and -$3.38.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 4 analysts. It ranges from a high estimate of $31.3M to a low estimate of $30.4M. As of. The current estimate, Outset Medical Inc’s year-ago sales were $28.67MFor the next quarter, 4 analysts are estimating revenue of $32.15M. There is a high estimate of $32.6M for the next quarter, whereas the lowest estimate is $31.3M.
A total of 4 analysts have provided revenue estimates for OM’s current fiscal year. The highest revenue estimate was $124.5M, while the lowest revenue estimate was $123.8M, resulting in an average revenue estimate of $124.03M. In the same quarter a year ago, actual revenue was $113.69MBased on 4 analysts’ estimates, the company’s revenue will be $137.07M in the next fiscal year. The high estimate is $140M and the low estimate is $134.5M.
